CoChat

Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management

Open access
Ma, Zu-Yi, Gong, Yuan-Feng, Zhuang, Hong-Kai, Zhou, Zi-Xuan, Huang, Shan-Zhou, Zou, Yi-Ping, Huang, Bo-Wen, Sun, Zhong-Hai, Zhang, Chuan-Zhao, Tang, Yun-Qiang, Hou, Bao-Hua · 2020 · World Journal of Gastroenterology
Cited by 196

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of tumors with complicated treatment options that depend on pathological grading, clinical staging, and presence of symptoms related to hormonal secretion. With regard to diagnosis, remarkable advances have been made: Chromogranin A is recommended as a general marker for pNETs. But other new biomarker modalities, like circulating tumor cells, multiple transcript analysis, microRNA profile, and cytokines, should be clarified in future investigations before clinical application. Therefore, the currently available serum biomarkers are insufficient for diagnosis, but reasonably acceptable in evaluating the prognosis of and response to treatments during follow-up of pNETs. Surgical resection is still the only curative therapeutic option for localized pNETs. However, a debulking operation has also been proven to be effective for controlling the disease. As for drug therapy, steroids and somatostatin analogues are the first-line therapy for those with positive expression of somatostatin receptor, while everolimus and sunitinib represent important progress for the treatment of patients with advanced pNETs. Great progress has been achieved in the combination of systematic therapy with local control treatments. The optimal timing of local control intervention, planning of sequential therapies, and implementation of multidisciplinary care remain pending.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3748/wjg.v26.i19.2305

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Metadata

Authors
Ma, Z.-Y., Gong, Y.-F., Zhuang, H.-K., Zhou, Z.-X., Huang, S.-Z., Zou, Y.-P., Huang, B.-W., Sun, Z.-H., Zhang, C.-Z., Tang, Y.-Q., & Hou, B.-H.
Venue
World Journal of Gastroenterology
Published
2020-05-21
Volume
26
Issue
19
Pages
2305-2322
ISSN
1007-9327 (ISSN-L)
OpenAlex
W3028511887
Cited by
196
References
2
FWCI
14.44
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management. https://app.cochat.ai/papers/10.3748/wjg.v26.i19.2305
The paper
Ma, Z.-Y., Gong, Y.-F., Zhuang, H.-K., Zhou, Z.-X., Huang, S.-Z., Zou, Y.-P., Huang, B.-W., Sun, Z.-H., Zhang, C.-Z., Tang, Y.-Q., & Hou, B.-H. (2020). Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v26.i19.2305

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.